Journal
NATURE CELL BIOLOGY
Volume 19, Issue 10, Pages 1274-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb3613
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81430070, 81661148048, 31371409]
- Chinese Academy of Sciences [QYZDB-SSW-SMC013, XDA12050101]
- Ministry of Science and Technology of China [2013CB910904]
- Science and Technology Commission of Shanghai Municipality [14431900800]
Ask authors/readers for more resources
Metastatic cancer is a systemic disease, and metastasis determinants might elicit completely different effects in various target organs. Here we show that tumour-secreted DKK1 is a serological marker of breast cancer metastasis organotropism and inhibits lung metastasis. DKK1 suppresses PTGS2-induced macrophage and neutrophil recruitment in lung metastases by antagonizing cancer cell non-canonical WNT/PCP-RAC1-JNK signalling. In the lungs, DKK1 also inhibits WNT/Ca2+-CaMKII-NF-kappa B signalling and suppresses LTBP1-mediated TGF-beta secretion of cancer cells. In contrast, DKK1 promotes breast-to-bone metastasis by regulating canonical WNT signalling of osteoblasts. Importantly, targeting canonical WNT may not be beneficial to treatment of metastatic cancer, while combinatory therapy against JNK and TGF-beta signalling effectively prevents metastasis to both the lungs and bone. Thus, DKK1 represents a class of Janus-faced molecules with dichotomous roles in organotropic metastasis, and our data provide a rationale for new anti-metastasis approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available